A federal judge told drug maker Johnson & Johnson it will not get to hold onto its patent for the rheumatoid arthritis drug Remicade. 

While the Affordable Care Act (ACA) and its expansion of Medicaid lowered the number of Americans without health coverage, millions are still uninsured, and a new study from the Commonwealth Fund aimed to identify who they are and why they aren’t covered.

The effects of major insurers—such as UnitedHealth, Humana and, most recently, Aetna—departing from some state health insurance exchanges will depend largely on where consumers live.

Biotechnology company ProclaRx named a new chief operation officer today as it switches up its executive team.

Sasmar Pharmaceuticals, a Belgium-based pharmaceutical manufacturer, has acquired Aquatrove Biosciences this week as it continues to expand its portfolio of biotechnology companies that will help improve its product pipeline.

Duke University professors Kevin Schulman, MD, and Barak Richman, JD, PhD, called on the CMS Innovation Center to focus on telemedicine and wearable devices, rather than accountable care organizations (ACOs) which integrate hospitals, to reduce the cost of care.

A letter from Aetna CEO Mark Bertolini obtained by the Huffington Post appears to contradict the insurer’s stance that pulling out of 11 Affordable Care Act (ACA) exchanges wasn’t connected to the government’s antitrust lawsuit against its proposed merger with Humana.

The FDA recently approved a cholesterol-lowering drug capable of preventing significant amounts of deaths, nonfatal MI and strokes. Unfortunately, most patients can’t afford it.